View in-depth coverage of the 2025 American Society of Clinical Oncology Annual Meeting.
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
Advertisement
Advertisement
2024
2023
2022
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
The panel concludes with a discussion on the early use of PARP inhibitors in patients with DNA repair mutations like BRCA1/2.
The panel delves into how de novo metastases signal more aggressive prostate cancer biology.
The panel weighs the role of next-generation sequencing and emphasizes how SPOP, TP53, and RB1 guide treatment decisions.
The panel considers the evolving management of oligometastatic prostate cancer, highlighting the role of MDT.
The panel reviews treatment options for newly diagnosed mHSPC, comparing data from key doublet trials.
The panel explores scenarios where PSMA PET may not be needed, as well as limitations of conventional imaging in trials.